Long-term effects of secukinumab on MRI findings in relation to clinical efficacy in subjects with active ankylosing spondylitis: an observational study

Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography

(2013) X Baraliakos et al.   ANNALS OF THE RHEUMATIC DISEASES

Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial

(2013) Dominique Baeten et al.   LANCET

Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study

(2011) Jürgen Braun et al.   ANNALS OF THE RHEUMATIC DISEASES

Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis

(2011) Praveena Chiowchanwisawakit et al.   ARTHRITIS AND RHEUMATISM

Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis

(2011) Troy Noordenbos et al.   ARTHRITIS AND RHEUMATISM

The diagnostic utility of magnetic resonance imaging in spondylarthritis: An international multicenter evaluation of one hundred eighty-seven subjects

(2010) Ulrich Weber et al.   ARTHRITIS AND RHEUMATISM

The fatty Romanus lesion: a non-inflammatory spinal MRI lesion specific for axial spondyloarthropathy

(2009) A. N. Bennett et al.   ANNALS OF THE RHEUMATIC DISEASES

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

(2009) M Rudwaleit et al.   ANNALS OF THE RHEUMATIC DISEASES

The relationship between inflammation and new bone formation in patients with ankylosing spondylitis

(2008) Xenofon Baraliakos et al.   ARTHRITIS RESEARCH & THERAPY